You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 11, June 13, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (186)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Quality of Life
 •Musculoskeletal Syndromes (Chronic Fatigue, Gulf War)
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Restless Legs Syndrome Prevalence and Impact

REST General Population Study

Richard P. Allen, PhD; Arthur S. Walters, MD; Jacques Montplaisir, MD, PhD; Wayne Hening, MD, PhD; Andrew Myers, PhD; Timothy J. Bell, PhD; Luigi Ferini-Strambi, MD

Arch Intern Med. 2005;165:1286-1292.

Background  Restless legs syndrome (RLS), a common sensorimotor disorder, has a wide range of severity from merely annoying to affecting sleep and quality of life severely enough to warrant medical treatment. Previous epidemiological studies, however, have failed to determine the prevalence of those with clinically significant RLS symptoms and to examine the life effects and medical experiences of this group.

Methods  A total of 16 202 adults (aged ≥18 years) were interviewed using validated diagnostic questions to determine the presence, frequency, and severity of RLS symptoms; respondents reporting RLS symptoms were asked about medical diagnoses and the impact of the disorder and completed the Short Form-36 Health Survey (SF-36). Criteria determined by RLS experts for medically significant RLS (frequency at least twice a week, distress at least moderate) defined "RLS sufferers" as a group most likely to warrant medical treatment.

Results  In all, 15 391 fully completed questionnaires were obtained; in the past year, RLS symptoms of any frequency were reported by 1114 (7.2%). Symptoms occurred at least weekly for 773 respondents (5.0%); they occurred at least 2 times per week and were reported as moderately or severely distressing by 416 (2.7%). Of those 416 (termed RLS sufferers), 337 (81.0%) reported discussing their symptoms with a primary care physician, and only 21 (6.2%) were given a diagnosis of RLS. The SF-36 scores for RLS sufferers were significantly below population norms, matching those of patients with other chronic medical conditions.

Conclusion  Clinically significant RLS is common (prevalence, 2.7%), is underdiagnosed, and significantly affects sleep and quality of life.



Author Affiliations: Department of Neurology, The Johns Hopkins University, Baltimore, Md (Dr Allen); New Jersey Neuroscience Institute at JFK Medical Center, Edison, and School of Graduate Medical Education, Seton Hall University, South Orange, NJ (Dr Walters); Departments of Psychiatry and Neurosciences, Université de Montréal, Montreal, Quebec (Dr Montplaisir); Department of Neurology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick (Dr Hening); Premark Services Ltd, Crawley Down, West Sussex, England (Dr Myers); Health Solutions, Research Triangle Institute, Research Triangle Park, NC (Dr Bell); and Department of Neurosciences, Università Vita–Salute San Raffaele, Milan, Italy (Dr Ferini-Strambi). Dr Bell is now with the Gastrointestinal Research and Development Group of GlaxoSmithKline, Research Triangle Park.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prevalence and Clinical Correlates of Restless Legs Syndrome in an Elderly French Population: The Synapse Study
Celle et al.
J Gerontol A Biol Sci Med Sci 2009;0:glp161v1-glp161.
ABSTRACT | FULL TEXT  

Association of Intronic Variants of the BTBD9 Gene With Tourette Syndrome
Riviere et al.
Arch Neurol 2009;66:1267-1272.
ABSTRACT | FULL TEXT  

RESTLESS LEGS SYNDROME WITH PERIODIC LIMB MOVEMENTS: A POSSIBLE CAUSE OF IDIOPATHIC HYPERCKEMIA
Della Marca et al.
Neurology 2009;73:643-645.
FULL TEXT  

Obesity and restless legs syndrome in men and women
Gao et al.
Neurology 2009;72:1255-1261.
ABSTRACT | FULL TEXT  

MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels
Xiong et al.
Hum Mol Genet 2009;18:1065-1074.
ABSTRACT | FULL TEXT  

Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS
Kushida et al.
Neurology 2009;72:439-446.
ABSTRACT | FULL TEXT  

Clinical and Genetic Description of a Family With a High Prevalence of Autosomal Dominant Restless Legs Syndrome
Young et al.
Mayo Clin Proc. 2009;84:134-138.
ABSTRACT | FULL TEXT  

Restless Legs Syndrome and Periodic Limb Movements
Phillips
ACCP Sleep Med Brd Rev 2009;4:287-292.
FULL TEXT  

Pneumatic Compression Devices Are an Effective Therapy for Restless Legs Syndrome: A Prospective, Randomized, Double-Blinded, Sham-Controlled Trial
Lettieri and Eliasson
Chest 2009;135:74-80.
ABSTRACT | FULL TEXT  

T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome
Astrakas et al.
Neurology 2008;71:911-916.
ABSTRACT | FULL TEXT  

Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trial
Hornyak et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:823-825.
ABSTRACT | FULL TEXT  

Sleep Disturbance in Bipolar Disorder: Therapeutic Implications
Plante and Winkelman
Am. J. Psychiatry 2008;165:830-843.
ABSTRACT | FULL TEXT  

Effect of Nonergot Dopamine Agonists on Symptoms of Restless Legs Syndrome
Baker et al.
Ann Fam Med 2008;6:253-262.
ABSTRACT | FULL TEXT  

Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage
Manconi et al.
Mult Scler 2008;14:86-93.
ABSTRACT  

Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study
Winkelman et al.
Neurology 2008;70:35-42.
ABSTRACT | FULL TEXT  

Periodic Limb Movements in Sleep -- Endophenotype for Restless Legs Syndrome?
Winkelman
NEJM 2007;357:703-705.
FULL TEXT  

Restless Legs Syndrome: Prevalence and Impact in Children and Adolescents The Peds REST Study
Picchietti et al.
Pediatrics 2007;120:253-266.
ABSTRACT | FULL TEXT  

Sleep Problems in Primary Care: A North Carolina Family Practice Research Network (NC-FP-RN) Study
Alattar et al.
J Am Board Fam Med 2007;20:365-374.
ABSTRACT | FULL TEXT  

EFFICACY AND SAFETY OF PRAMIPEXOLE IN RESTLESS LEGS SYNDROME
Kruszewski et al.
Neurology 2007;68:1641-1642.
FULL TEXT  

Prevalence of Restless Legs Syndrome Among Native South Americans Residing in Coastal and Mountainous Areas
Castillo et al.
Mayo Clin Proc. 2006;81:1345-1347.
ABSTRACT | FULL TEXT  

Efficacy and safety of pramipexole in restless legs syndrome
Winkelman et al.
Neurology 2006;67:1034-1039.
ABSTRACT | FULL TEXT  

A novel autosomal dominant restless legs syndrome locus maps to chromosome 20p13.
Levchenko et al.
Neurology 2006;67:900-901.
ABSTRACT | FULL TEXT  

Sleep Disorders and Attention-Deficit Hyperactivity Disorder in Children: A Missing Differential Diagnosis
Archbold
J Am Psychiatr Nurses Assoc 2006;12:216-224.
ABSTRACT  

Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding
Cervenka et al.
Brain 2006;129:2017-2028.
ABSTRACT | FULL TEXT  

Prevalence and Correlates of Restless Legs Syndrome: Results From the 2005 National Sleep Foundation Poll
Phillips et al.
Chest 2006;129:76-80.
ABSTRACT | FULL TEXT  

Ropinirole in the Treatment of Patients With Restless Legs Syndrome: A US-Based Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Bogan et al.
Mayo Clin Proc. 2006;81:17-27.
ABSTRACT | FULL TEXT  

Restless Legs Syndrome: Fairly Common, Very Disruptive
JWatch Psychiatry 2005;2005:9-9.
FULL TEXT  

Restless Legs Syndrome: Fairly Common, Very Disruptive
Journal Watch Dermatology 2005;2005:13-13.
FULL TEXT  

Restless Legs Syndrome: Fairly Common, Very Disruptive
JWatch General 2005;2005:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.